Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2025 08:00 ET | Source: Heron Therapeutics, Inc.

Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress

Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - $163 million and adjusted EBITDA of $9.0 - $13.0...
October 29, 2025 17:58 ET | Source: Heron Therapeutics, Inc.

Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors

CARY, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced the appointment of Thomas...
October 21, 2025 16:20 ET | Source: Heron Therapeutics, Inc.

Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025